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ABSTRACT
Oral hairy leukoplakia (OHL) is defined as an asymptomatic white patch with vertical corrugation pattern the
lateral borders of the tongue, that is associated with Epstein-Barr Virus (EBV) infection. Generally, it is related to
immunosuppressive condition found in HIV-positive patients and patients undergoing immunosuppressive therapy.
Sometimes, its clinical appearances could mimic other white lesions. Although most OHL cases are found in HIV
seropositive individuals, finding in the immunocompetent individuals has also been reported. Appropriate clinical
evaluations and laboratory investigations are important for patient’s comprehensive management. Objective: To
report a finding of oral hairy leukoplakia as a clinical indicator of an immunosuppressive condition in otherwise a
clinically healthy-looking individual and to discuss the challenges on patient management. Case Report: A 40 yearold man presented with asymptomatic, bilateral homogenous white hyperkeratotic plaques with a hairy appearance
located on the dorsal of the tongue, extended to the lateral tongue mucosa. The patient failed to remember the lesion’s
first appearance, until three weeks before a visit. Working diagnosis of OHL was made with differential diagnoses
including white sponge nevus, leukoplakia and oral lichen planus. Histopathological assessment was consistent
with OHL. Challenges on patient management include identifying possible risk factors and assuring patient for
HIV testing. Conclusion: This case reported findings of OHL as the first clinical indicator of immunosuppressive
condition that might be related to HIV-infection.
Keywords: Acquired Immunodeficiency Syndrome, Epstein-Barr Virus, Human Immunodeficiency Virus,
oral hairy leukoplakia

INTRODUCTION
Oral hairy leukoplakia (OHL) is a white lesion commonly
found in individuals with immunodeficiency. OHL is
a unique white lesion presenting as an asymptomatic
white patch with a vertical corrugation pattern on
the lateral border of the tongue and associated with
Epstein-Barr Virus (EBV) infection.1 OHL could
be an early indicator of immunosuppresion such as
hematologic malignancies, long-term uses of systemic
steroid, undiagnosed HIV/AIDS. It is an indicator

of those who in the progression of state of AIDS for
example seropositive homosexual men.2 In general,
OHL is recognized as a form of an opportunistic
infection associated with HIV infection. The ability to
recognize the manifestations of systemic conditions is
a key in providing a comprehensive care with an early
appropriate medical intervention in order to reduce the
mortality rate of patients and enhancing the quality
of life.3,4
54
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Figures 1(a)-(d). The homogenous hairy white patches along
the dorsolateral border and ventral tongue surfaces.

Figure 3. (a) Ballooning degeneration of the epithelial cells
in the stratum spinosum was demonstrated (H&E, original
magnification x100); (b) Higher magnification showed
perinuclear halos and peripheral margination of the chromatin
in the nuclei of the spinous cells (H&E, original magnification
x400).

Figure 2. (a) The clinical feature reveals the lesion on the
right dorsolateral surface of the tongue where the biopsy
was performed; (b) The clinical feature showed a completely
healed wound on the following visit.

OBJECTIVE
The objective of this case report was to present a finding
of OHL as a clinical indicator of an immunosuppressive
condition in a clinically healthy-looking individual and
to discuss the challenges on patient management.

CASE REPORT
A 40 year-old man who looked apparently healthy
came to the Dental Hospital Universitas Indonesia,
complaining of the appearance of asymptomatic
bilateral white plaques located on the dorso lateral

borders of his tongue. The patient failed to remember
the lesion’s first appearance, until three weeks before
this visit. The patient was worried that the appearance
of white patches on the tongue was a sign of malignancy
especially cancer of the tongue or HIV infection. He
had never been tested for HIV before. He denied any
medical problems, risks or lifestyles associated with
HIV infection. The patient reported no fever or pain
when swallowing or chewing. Numbness and a burning
sensation on the tongue were also denied. The intraoral
examination showed bilateral white hyperkeratotic
homogenous patches on the lateral borders of the
tongue along the region of teeth 34-37 and 44-47. The
lesions appeared to spread downwards to the ventral
surfaces of the tongue and were unscrapable, painless,
hairy or corrugated in appearance and showed no
induration or erythema (Figure 1 a-d).
The working diagnosis of oral hairy leukoplakia was
made with differential diagnoses of white sponge
nevus, leukoplakia and oral lichen planus. In order
to obtain the definitive diagnosis, the patient was
scheduled for biopsy for histopathology examination.
On the following visit, the intraoral examination
revealed white patches with erythematous borders
that could be scrapped off on the soft palate and both
sides of buccal mucosae. These clinical appearances
were consistent with pseudomembranous candidiasis.
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On that visit, the patient was prescribed with nystatin
oral suspension four times daily for two weeks. He
was scheduled for biopsy and basic blood laboratory
tests in two-week time at the Department of Oral and
Maxillofacial Surgery.

resolves under HAART or ARV medication, if
associated with HIV infection.

On the day of the biopsy, intraoral examination
showed that the pseudomembranous candidiasis
lesion did not completely disappear. The patient
admitted that he was not properly adhered on taking
medication prescribed. He was then prescribed
with twice daily 50 mg of Fluconazole orally for
7 days. Biopsy was performed (Figure 2a) and the
specimen was sent for histopathological assessment
at the Department of Anatomic Pathology, Faculty of
Medicine, University of Indonesia. On the following
visit, intraoral examination showed complete healing of
the wound at the operation site (Figure 2 a,b). Finally,
the histopathological assessment confirmed that the
white lesion was consistent with OHL exhibiting the
ballooning spinous cells without any sign of dysplastic
changes (Figure 3 a,b).

Oral hairy leukoplakia is one of the most common
early lesions in immunocompromised patients. OHL is
a flat, corrugated or hairy lesion usually located on the
lateral border of the tongue, unilaterally or bilaterally.
OHL cannot be removed by scraping.5,6 Generally,
OHL is related to immunosuppressive conditions
found in HIV-positive patients and patients undergoing
immunosuppressive therapy. Although most OHL cases
are found in HIV-seropositive individuals, finding
in the absence of immunosuppression has also been
reported. Previous studies have suggested that OHL
is an early indicator of HIV infection and be related
to the progression of AIDS.1 Although typically,
the clinical feature of OHL is unique, its clinical
appearances in some cases may mimic other oral white
lesions suggesting a confirmation of the diagnosis by
histopathologic examination in those cases. Oral white
lesions that could have similar appearances to OHL
include oral white sponge nevus, chronic hyperplastic
candidiasis, pseudomembranous candidiasis, oral
lichen planus, idiopathic oral leukoplakia, frictional
keratosis, geographic tongue and “galvanic” lesions.3,6

DISCUSSION

Two weeks after the biopsy, the patient was scheduled
for private consultation about the results of the
histopathologic assessment of OHL. The patient was
concerned about the definitive diagnosis of the lesion
and its connection with HIV infection. The patient was
then given explanations about OHL as an indicator
of HIV infection and a lifestyle related to the lesion.
Unexpectedly, the patient became uneased and worried
about what he was told. He decided to leave the clinic
and asked for another appointment. We informed the
patient that the diagnosis of HIV infection could not
be done only by having a clinical examination. In fact,
he still needed some tests to confirm the diagnosis.
In addition, it was essential for him to have pre- and
post-counseling about HIV infection and referral to
the internal medicine when the definitive diagnosis
was made. Reassurance and supports were given to the
patient continuously. Although the patient did not decide
to be scheduled for another appointment, he promised
he would receive the treatment when he was ready. In
fact, for two months, we got communication by phone,
for consulting the test and assuring medication. Then
after 3 months, the patient came to the Dental Hospital,
and give the result of the test. He told us that he was
positive HIV, in which CD4 is 38. He also took the ARV
medication. On the oral examination, the lesion of OHL
was remission after he consumed ARV medication. The
manajement of this patient was completely resolved,
with the remission of the OHL lesion, and the patient
was under ARV treatment by internist.

Etiologically, OHL is believed to be associated with
an infection with EBV, a double-stranded DNA virus
that can replicate in the epithelial cells as a primary
site. Based on the histopathological examination, an
absence or a high reduction of Langerhans cells in the
lesion was reported. Langerhans cells are the antigenpresenting immune cells that are responsible for viral
infection.7 Detection of EBV DNA in the epithelial cells
was studied in 25 OHL cases by using noninvasive
diagnostic techniques, the filter in situ hybridization
(FISH) and cytospin in situ hybridization (CISH).
The results showed that all cases were EBV-positive
by FISH, and 23 cases were EBV-cases by CISH.8 By
combined methods of immunohistochemistry, DNA
in situ hybridization, and lectin histochemistry, the
life cycle of EBV in the keratinocytes, in which both
EBV protein and DNA were found, was identified.9
Moreover, the pathogenesis of OHL was suggested
to be involved in a migration of the EBV-infected
monocytes/macrophages from the submucosa into the
spinosum or granulosum layer of the oral epithelium.10
As the AIDS disease progresses, reflected by a continual
loss of CD4 lymphocytes, the oral cavity becomes more
susceptible to various oral lesions as shown in Table 1.11
Candidiasis was the most common lesion seen in patients
with CD4+ counts less than 200 (28 cases), followed by
periodontitis (7 cases). OHL was found in three patients
with CD4+ counts less than 200, and one patient with
CD4+ counts at the range of 200- 499.11

The lesion of OHL can be diagnosed by clinically and
histopathological examination. We confirm that in
most cases, oral hairy leukoplakia can be diagnosed
clinically and does not require a confirmatory biopsy.
It does not require specific treatment and frequently
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Journal of Dentistry Indonesia 2016, Vol. 23, No.2, 54-58
Table 1. Oral manifestations related to CD4+ counts
CD4+ count Periodontitis Gingivitis Herpes Candidiasis
cell/mm3

Hairy
Leukoplakia

Ulceration

Kaposi’s
Sarcoma

Non Hodgkin
Lymphoma

<200
>200 <499
>500

3
1
0

1
3
0

3
0
0

1
0
0

7
9
1

3
2
0

3
2
0

28
9
1

The histology examination of OHL shows acanthotic
parakeratinized stratified squamous epithelium with
finger-like projections, giving a clinical feature of
a corrugated or hairy appearance. Typically, the
upper spinous cell layer reveals the presence of the
koilocytes occurred by ballooning degeneration of the
epithelial cells.12,13 Microscopically, the koilocytes are
the vacuolated spinous cells with pyknotic nuclei and
perinuclear halos.
There is a specific patient’s management of OHL
especially for undiagnosed HIV infection, especially
good communication by giving the right information
about the risk factors of OHL including HIV infection.
The dentists who are get involved need to be skillful
in interviewing patients and good listeners to get
the information about patient’s lifestyle that might
be related to a risk factor for HIV infection. For
undiagnosed HIV-infected persons, the principal
patients’ management focuses on restoring the patient’s
comfort, eliminating secondary infections of bacteria,
viruses and fungi, and preventing the possibility
of other oral diseases.5 The pre-test counseling for
undiagnosed HIV patients with a consideration of the
human rights is also needed.14
There are three principles of HIV testing, (the
“three Cs”) are established as norms: counseling
and information providing about HIV/AIDS before
and after the test; consent to tests by suspicious
individuals in an informed, specific, and voluntary
way; and confidentiality of the test results and the fact
of seeking a test.14 Moreover, the strategies of relaxing
counseling by reducing stigma and discrimination
related to HIV infection or AIDS would give patient’s
confidence to talk about history of his/her life style
and lead to patient’s decision making to have a test
for HIV infection.14 There are rapid HIV screening
tests for antibodies against the HIV in individuals
who have initially infected within a month and a half
to up to six months. It is important to note that during
the initial infection before the development of the
antibodies, a stage known as “acute HIV infection,”
those individuals will not have a positive test result
and could make a greater risk of transmission. 15 It was
reported that undiagnosed HIV infection is a major
drive of the transmission of HIV causing the incidence
of HIV infection in the United States of over 50,000
annually. It was described that 18 % of infected persons
nationally are unaware of their HIV status. In fact,
44-66 % of new HIV infections are attributed to this
modest proportion of individuals with undiagnosed

HIV.16 Therefore, to eliminate the global HIV/AIDS
epidemic, there is a need for an action to promote the
“seek, test, treat, and retain” (STTR) strategy. This
strategy consists of seeking people at risk who have
not been recently tested for HIV infection (seeking),
engaging them in HIV testing (testing), initiating,
monitoring, and maintaining treatment for those
testing positive (treating) and retaining patients in
care (retaining).16 One of the seeking strategies is to
detect the oral lesion that could show a clinical sign
of the immunodeficiency status of HIV. In 2009, the
Government of Canada initiated the Seek and Treat
Strategic for Optimal Prevention of HIV/AIDS in BC
(STOP HIV/AIDS in the British Columbia province,
BC). As a result, the morbidity, mortality, and new
HIV diagnoses have continued to decrease steadily
in BC.17 In China, the number of people being tested
for HIV had increased almost four folds b 2007 to 101
million in 2012, between 2007 to 2012. The number
of newly identified HIV cases had increased from
48,074 to 82,434 cases. Subsequently, started in 2011,
China has taken further steps to promote HIV testing
and treatment particularly targeting people at risk of
HIV infection in each province across the nation. This
effort has significantly improved the identification of
infected individuals and the number of new patients
receiving earlier treatment has increased, leading to
a reduction in the mortality rate of patients.17 In an
Asia-Pacific region, there were 350000 newly HIVinfected individuals especially who were the drug
users and homosexuals or transgender persons. HIVinfected homosexuals in Indonesia, India, Malaysia
and some certain other Asian countries are considered
inaccessible and victimized because of the stigma,
discrimination, and injustice against.4 Collectively,
a proper management and counselling in newly HIVinfected individuals have to be established and a
screening of the oral cavity of HIV-infected persons
is suggested to be regularly performed.4
In Indonesia, the Ministry of Health of Indonesia
reported that there were totally 150,296 HIV-infected
individuals and 55,799 patients with AIDS from
1987 until September 2014 and 7335 HIV-infected
individuals and 176 patients with AIDS during
the quarter of July to September 2014. The modes
of transmission include heterosexual (34,305),
homosexual/bisexual (1,366), Injecting Drug Users
(IDU) (8,462), blood transfusion (130) and perinatal
transmission (1,506), and unknown (9,536).18 The AIDS
epidemic in Indonesia (2007) showed the prevalence
of HIV infection among different groups of people
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as follows; 10.4% among direct sex workers; 4.6%
among indirect sex workers; 24.4% among transgender;
0.8% among the clients of female sex workers; 5.2%
among MSM; and 52.4% among IDU. Interestingly,
it was found that the transmission of HIV infection
is rising among MSM.19 To eliminate the rising of
the transmission, the interventions of Government of
Indonesia is needed by providing supportive policies
to the key populations, promoting the use of condoms,
and reducing stigma and discrimination against HIVinfected individuals and patients with AIDS especially
the MSM group.19

8.

9.

10.

CONCLUSION
In summary, OHL could be an early sign of undiagnosed
immunosuppression, particularly who might be
undergoing the progression of HIV infection as
reported here. The goal of the patient’s management
was to establish the definitive diagnosis and to assure
the patient to immediately have tests for HIV infection
and CD4 counts.
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